On ECHEMI
Home > Drugs > Sinopharm Group Luya(Shandong)Pharmaceutical Co., Ltd.
Sinopharm Group Luya(Shandong)Pharmaceutical Co., Ltd.
  • Founded in:

    2000-11-06
  • Country:

    China China
  • Address:

    No. 3, Hongxing West Road, Rencheng District, Jining City, Shandong Province
  • Tax NO.:

    91370800706117112C
  • Registered Funds:

    24.5293 million yuan
  • Website:

  • Email:

Related Drugs
Cefdizime Sodium for Injection
Cefdizime Sodium
Name Description Content CAS NO. Registered Holders
Cefodizime

This product belongs to the third generation of cephalosporin, has a broad-spectrum antibacterial effect, and is stable to β-lactamase produced by most bacteria. This product is mainly effective against a variety of G and G- bacteria and anaerobic bacteria. It has an immunomodulatory effect, that is, it can be used as a biological response modifier (BRM) to increase CD4 in the body, thereby increasing the CD4/CD8 value and playing a synergistic bactericidal effect. The mechanism of action of this product is that this product achieves a bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

More

This product belongs to the third generation of cephalosporin, has a broad-spectrum antibacterial effect, and is stable to β-lactamase produced by most bacteria. This product is mainly effective against a variety of G and G- bacteria and anaerobic bacteria. It has an immunomodulatory effect, that is, it can be used as a biological response modifier (BRM) to increase CD4 in the body, thereby increasing the CD4/CD8 value and playing a synergistic bactericidal effect. The mechanism of action of this product is that this product achieves a bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

69739-16-8 1
Cefdizime Sodium for Injection
Cefdizime Sodium
Name Description Content CAS NO. Registered Holders
Cefodizime

This product belongs to the third generation of cephalosporin, has a broad-spectrum antibacterial effect, and is stable to β-lactamase produced by most bacteria. This product is mainly effective against a variety of G and G- bacteria and anaerobic bacteria. It has an immunomodulatory effect, that is, it can be used as a biological response modifier (BRM) to increase CD4 in the body, thereby increasing the CD4/CD8 value and playing a synergistic bactericidal effect. The mechanism of action of this product is that this product achieves a bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

More

This product belongs to the third generation of cephalosporin, has a broad-spectrum antibacterial effect, and is stable to β-lactamase produced by most bacteria. This product is mainly effective against a variety of G and G- bacteria and anaerobic bacteria. It has an immunomodulatory effect, that is, it can be used as a biological response modifier (BRM) to increase CD4 in the body, thereby increasing the CD4/CD8 value and playing a synergistic bactericidal effect. The mechanism of action of this product is that this product achieves a bactericidal effect by inhibiting the biosynthesis of bacterial cell wall mucopeptides.

69739-16-8 1
Group A Streptococcus for injection
Main ingredients: Group A hemolytic streptococci treated with penicillin
Name Description Content CAS NO. Registered Holders
Penicillin-treated group A hemolytic streptococci

Group A Streptococcus has the function of directly killing tumor cells, activating host cell immunity, and increasing the activity of T cells and NK cells; combined with chemotherapy, it can improve the efficacy and may reduce the effect of chemotherapy drugs on the bone marrow, and can regulate T cell subpopulations to increase the overall value of T3, T4, and T4/T8 ratio.

More

Group A Streptococcus has the function of directly killing tumor cells, activating host cell immunity, and increasing the activity of T cells and NK cells; combined with chemotherapy, it can improve the efficacy and may reduce the effect of chemotherapy drugs on the bone marrow, and can regulate T cell subpopulations to increase the overall value of T3, T4, and T4/T8 ratio.

0
Group A Streptococcus for injection
Main components: Group A hemolytic Streptococcus treated with penicillin.
Name Description Content CAS NO. Registered Holders
Penicillin-treated group A hemolytic streptococci

Group A Streptococcus has the function of directly killing tumor cells, activating host cell immunity, and increasing the activity of T cells and NK cells; combined with chemotherapy, it can improve the efficacy and may reduce the effect of chemotherapy drugs on the bone marrow, and can regulate T cell subpopulations to increase the overall value of T3, T4, and T4/T8 ratio.

More

Group A Streptococcus has the function of directly killing tumor cells, activating host cell immunity, and increasing the activity of T cells and NK cells; combined with chemotherapy, it can improve the efficacy and may reduce the effect of chemotherapy drugs on the bone marrow, and can regulate T cell subpopulations to increase the overall value of T3, T4, and T4/T8 ratio.

0
Ifosfamide for injection
The main ingredient of this product is ifosfamide.
Name Description Content CAS NO. Registered Holders
Ifosfamide

It is hydrolyzed by phosphatase or phosphatase in the liver or tumor in the body and becomes activated phosphoramide nitrogen mustard. Its mechanism of action is to cross-link with DNA, inhibit DNA synthesis, and interfere with RNA function. It is a non-specific drug for the cell cycle. It has a broad anti-tumor spectrum and has inhibitory effects on many tumors.

More

It is hydrolyzed by phosphatase or phosphatase in the liver or tumor in the body and becomes activated phosphoramide nitrogen mustard. Its mechanism of action is to cross-link with DNA, inhibit DNA synthesis, and interfere with RNA function. It is a non-specific drug for the cell cycle. It has a broad anti-tumor spectrum and has inhibitory effects on many tumors.

3778-73-2 24
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.